Innovative Medical Device Offers Patients a Catalyst for Regaining Control of Diabetes and Weight; Targeted Rollout Begins with Centers of Excellence LEXINGTON, Mass.--(BUSINESS WIRE)-- GI Dynamics, a ...
GI Dynamics has lost the right to sell its Type 2 diabetes and obesity device in the European Union. SGS, the notified body for EndoBarrier, pulled the CE Certificate of Conformity over the weekend in ...
GI Dynamics' EndoBarrier device has hit a couple of snags on its route to FDA approval, including the termination of a pivotal trial and the suspension of its CE mark. () GI Dynamics announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results